Influx Healthtech IPO Closes Oversubscribed, GMP Indicates 40% Listing Upside
Influx Healthtech’s SME IPO, which opened on June 18 and closed today, received an overwhelming response from retail and high-net-worth investors. With strong subscription numbers and a healthy grey market premium, the issue sets the stage for a potentially strong listing on the NSE SME platform. Subscription Status: Oversubscription Across Categories By end of trading…